Table 1 Baseline Characteristics of Patients in the Cerebrolysin and Saline Groups
|  | Cerebrolysin n = 25 | Saline n = 25 | P-value |
|---|---|---|---|
Patient Factors | |||
 Age, mean + SD (range), years | 52 + 9 (31–65) | 54 + 11 (37–70) | 0.72 |
  > 65 years | 2 | 4 | 0.67 |
 Female | 16 | 18 | 0.76 |
 Smoker | 12 | 9 | 0.39 |
 Pre-existing hypertension | 11 | 5 | 0.07 |
 Baseline MAP, mean + SD, mmHg | 127 + 28 | 122 + 22 | 0.45 |
 Median CCI | 1 | 1 | 1.00 |
Disease Factors | |||
 Modified WFNS |  |  | 0.79 |
  I | 11 | 14 |  |
  II | 4 | 1 |  |
  III | 1 | 3 |  |
  IV | 8 | 6 |  |
  V | 1 | 1 |  |
 APACHE II score, mean + SD | 11 + 5 | 9 + 5 | 0.14 |
 Modified Fisher CT Grade |  |  | 0.07 |
  I | 3 | 7 |  |
  II | 3 | 5 |  |
  III | 12 | 6 |  |
  IV | 7 | 7 |  |
 Hijdra score, mean + SD | 17 + 6 | 16 + 7 | 0.64 |
 Hijdra score > 22 | 6 | 8 | 0.53 |
 Hydrocephalus | 11 | 11 | 1.00 |
 Intraventricular hemorrhage | 10 | 10 | 1.00 |
 Intracerebral hemorrhage | 6 | 6 | 1.00 |
 Rebleeding | 0 | 1 | 1.00 |
 Aneurysm location |  |  | 0.53 |
  ICA | 10 | 11 |  |
  ACA/ AComA | 5 | 9 |  |
  MCA | 7 | 3 |  |
  PC | 3 | 2 |  |
Treatment Factors | |||
 Aneurysm treatment | |||
  Endovascular therapy | 16 | 19 | 0.11 |
  Clipping | 9 | 6 | 0.36 |